Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Repatha
Repatha
Supreme Court rules against Amgen bid to revive cholesterol drug patents
KFGO/Reuters
Thu, 05/18/23 - 11:24 am
Supreme Court
Amgen
Sanofi
Regeneron
patents
Repatha
legal
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Amgen
Sanofi
Regeneron
Supreme Court
legal
innovation
patents
Repatha
Praluent
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Amgen
Repatha
patents
Supreme Court
Sanofi
Regeneron
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Amgen
patents
Supreme Court
Repatha
Sanofi
Regeneron
Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Fierce Pharma
Wed, 06/1/22 - 07:36 pm
Regeneron
Amgen
FDA
antitrust
legal
Repatha
Praluent
Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron
Fierce Pharma
Mon, 11/29/21 - 10:44 pm
Amgen
Sanofi
Regeneron
patents
Supreme Court
Repatha
Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead
Fierce Pharma
Mon, 11/22/21 - 10:13 pm
Amgen
biosimilars
Otezla
Repatha
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Mon, 11/15/21 - 11:55 pm
Merck
PCSK9 inhibitors
Amgen
Repatha
Esperion
Sanofi
Regeneron
Praluent
Amgen receives FDA approval for Repatha to treat pediatric HeFH patients
Pharmaceutical Business Review
Mon, 09/27/21 - 11:00 am
Amgen
Repatha
FDA
pediatric
HeFH
Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron
Fierce Pharma
Tue, 06/22/21 - 11:56 am
Amgen
PCSK9 inhibitors
Sanofi
Regeneron
patents
Repatha
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Fri, 02/12/21 - 10:48 am
Amgen
patents
Sanofi
Regeneron
Praluent
Repatha
Merck
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
Sun, 08/30/20 - 11:25 pm
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
Fierce Pharma
Sat, 03/28/20 - 11:30 pm
ACC
Repatha
HIV
clinical trials
Amgen
Two Big Drug Flops Show How Health-Care Economics Have Changed
Bloomberg
Fri, 01/10/20 - 10:34 am
drug pricing
Sanofi
Amgen
Praluent
Repatha
AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients
Fierce Pharma
Mon, 11/18/19 - 10:06 am
AHA
Amgen
Repatha
PCSK9 inhibitor
heart attacks
Amgen slashes price tag on cholesterol medicine Repatha by 60% for 2020
Yahoo/Reuters
Thu, 10/24/19 - 10:21 am
Amgen
drug pricing
Repatha
MedCo's PCSK9 challenger steals the show at ESC with winning data
Fierce Pharma
Mon, 09/2/19 - 12:27 pm
Medicines Company
ESC
PCSK9 inhibitors
inclisiran
Repatha
Praluent
European Society of Cardiology
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Wed, 08/28/19 - 10:52 pm
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Tue, 08/27/19 - 12:04 pm
Amgen
Regeneron
Sanofi
Praluent
Repatha
Medicines Company
PCSK9 inhibitors
inclisiran
German court blocks sale of Sanofi, Regeneron cholesterol drug
Biopharma Dive
Thu, 07/11/19 - 05:25 pm
patents
Amgen
Sanofi
Regeneron
Germany
Praluent
Repatha
Pages
1
2
3
4
5
6
7
8
next ›
last »